These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 155971)
1. Clinical and experimental studies on immunotherapy in malignant lymphoma. Kimura I Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1142-51. PubMed ID: 155971 [No Abstract] [Full Text] [Related]
2. In vivo antitumor activity of neocarzinostatin (NCS)-tumor antibody conjugate against a transplantable human leukemia cell line (BALL-1). Kimura I; Tsubota T; Ohnoshi T; Sato Y; Okazaki M; Manabe Y; Abe S Jpn J Clin Oncol; 1983 Jun; 13(2):425-33. PubMed ID: 6224954 [TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of human leukemic cells (CCRF-CEM) by agarose-immobilized neocarzinostatin. Lazarus H; Raso V; Samy TS Cancer Res; 1977 Oct; 37(10):3731-6. PubMed ID: 143343 [TBL] [Abstract][Full Text] [Related]
5. [Reinduction chemotherapy of acute leukemia with neocarzinostatin and other conventional antileukemic agents (author's transl)]. Nagao T; Kammura O; Nozaki H; Takahashi Y; Niiya K Rinsho Ketsueki; 1976 Aug; 17(8):838-43. PubMed ID: 144198 [No Abstract] [Full Text] [Related]
6. [Combination chemotherapy with neocarzinostatin (NCS) and other antitumor agents for advanced carcinoma of the digestive organs--improved clinical effect with NFO therapy]. Maeta M; Koga S; Shimizu N; Osaki Y; Hirai Y; Kato K; Masaki T; Maeta K; Kishimoto H; Watanabe S; Sugihara T; Iwasaki T; Tasaki M; Abe J; Yamashiro N Gan To Kagaku Ryoho; 1982 Oct; 9(10):1742-8. PubMed ID: 6223587 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of zinostatin in children with late-stage acute lymphocytic leukemia: a Pediatric Oncology Group Study. Sexauer C; Kim T; Nix W; Berry DH; Morgan S Cancer Treat Rep; 1981; 65(1-2):173-4. PubMed ID: 6452947 [No Abstract] [Full Text] [Related]
8. [Malignant lymphoma--recent progress in diagnosis and treatment. 3. Progress in therapeutic results. (2). Treatment of malignant lymphoma with special reference to chemotherapy and immunotherapy]. Shirakawa S; Karitani Y Nihon Naika Gakkai Zasshi; 1983 Oct; 72(10):1329-35. PubMed ID: 6373976 [No Abstract] [Full Text] [Related]
9. [Application of chimeric Fab fragments of monoclonal antibody A7 for targeting chemotherapy against pancreatic cancer]. Otsuji E; Yamaguchi T; Matsumura H; Nishida T; Yamamoto K; Tsuruta H; Okamoto K; Yata Y; Kitamura K; Takahashi T Gan To Kagaku Ryoho; 1997 Dec; 24(15):2285-7. PubMed ID: 9422075 [No Abstract] [Full Text] [Related]
10. [Arterial administration of high molecular weight antitumor agent, SMANCS dissolved in ethiodol for various malignant solid tumors]. Konno T; Iwai K; Maki S; Uchida M; Ogata K; Tashiro S; Miyauchi Y; Yokoyama I; Maeda H Nihon Gan Chiryo Gakkai Shi; 1983 Oct; 18(7):1845-51. PubMed ID: 6323597 [No Abstract] [Full Text] [Related]
11. [Targeting effect of transferrin-neocarzinostatin conjugate by receptor-mediated endocytosis]. Urushizaki I Nihon Rinsho; 1989 Jun; 47(6):1423-31. PubMed ID: 2528008 [No Abstract] [Full Text] [Related]
12. Studies on surgical adjuvant chemotherapy for colorectal cancer and administration of neocarzinostatin into the lumen of the colon or rectum using a double balloon catheter and iontophoresis. Akao S Nihon Geka Hokan; 1981 Jan; 50(1):67-82. PubMed ID: 6456709 [No Abstract] [Full Text] [Related]
13. [Preoperative administration of antineoplastic agents against gastric cancer. V. Clinical evaluation of combined chemotherapy with neocarzinostatin (NCS) and 5-fluorouracil (combined NF therapy) (author's transl)]. Okada K; Kitade F; Mabuchi A; Osawa N; Yasuda M; Kawashima Y; Yagi A; Yamada S; Sakuramoto K; Okajima K; Kita R; Sumida T; Kasagawa O Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):834-41. PubMed ID: 159328 [No Abstract] [Full Text] [Related]
14. [Local chemotherapy of malignant glioma. Intra-tumoral administration of neocarzinostatin]. Uemura S; Matsukado Y; Kuratsu J; Sonoda H; Ohtsuka T; Yoshioka S; Yamada M Neurol Med Chir (Tokyo); 1986 Jun; 26(6):468-74. PubMed ID: 2430207 [No Abstract] [Full Text] [Related]
15. [Anti-tumor effect of transferrin-neocarzinostatin conjugate which is taken up by cells with receptor medicated endocytosis]. Kohgo Y; Nishisato T; Kondo H; Matsumoto S; Kato J; Tsushima N; Niitsu Y; Urushizaki I Nihon Gan Chiryo Gakkai Shi; 1986 Apr; 21(3):641-6. PubMed ID: 3016123 [No Abstract] [Full Text] [Related]
16. [Intratumoral administration of monoclonal antibody-drug conjugate for treatment of pancreatic cancer]. Otsuji E; Yamaguchi T; Matsumura H; Nishida T; Yamamoto K; Tsuruta H; Okamoto K; Yata Y; Kitamura K; Takahashi T Gan To Kagaku Ryoho; 1998 Jan; 25(1):135-7. PubMed ID: 9464341 [No Abstract] [Full Text] [Related]
17. Immunotherapy of leukemia and lymphoma. Murphy S; Hersh E Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506 [No Abstract] [Full Text] [Related]
18. Clinical evaluation of preoperative combined chemotherapy with neocarzinostatin (NCS) and 5-Fluorouracil (combined NF therapy) against gastric cancer. Okada K; Kitade F; Kawashima Y; Yamada S; Sakuramoto K; Okajima K Bull Osaka Med Sch; 1981 Oct; 27(2):65-78. PubMed ID: 6295535 [No Abstract] [Full Text] [Related]
19. [Experimental study of intralymphatic chemotherapy in rabbits]. Satomi A; Takada Y; Ishida K Gan To Kagaku Ryoho; 1987 Jul; 14(7):2262-8. PubMed ID: 2955746 [TBL] [Abstract][Full Text] [Related]